Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina

J. G. Hensler, D. J. Cotterell, M. L. Dubocovich

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Superfusion with dopamine (0.1 μM-10 mM) evokes calcium-dependent [3H]acetylcholine release from rabbit retina labeled in vitro with [3H]choline. This effect is antagonized by the D-1 dopamine receptor antagonist SCH 23390. Activation or blockade of D-2 dopamine, alpha-2 or beta receptors did not stimulate or attenuate the release of [3H]acetylcholine from rabbit retina. Dopamine receptor agonists evoke the release of [3H]acetylcholine with the following order of potency: apomorphine ≥ SKF(R)82526 > SKF 85174 > SKF(R)38393 ≥ pergolide ≥ dopamine (EC50 = 4.5 μM) > SKF(S)82526 ≥ SKF(S)38393. Dopamine receptor antagonists inhibited the dopamine-evoked release of [3H]acetylcholine: SCH 23390 (IC50 = 1 nM) > (+)-butaclamol ≥ cis-fluphenthixol >fluphenazine > perphenazine > trans-flupenthixol > R-sulpiride. The potencies of dopamine receptors agonists and antagonists at the dopamine receptor mediating [3H]acetylcholine release is characteristic of the D-1 dopamine receptor. These potencies were correlated with the potencies of dopamine receptor agonists and antagonists at the D-1 dopamine receptor in rabbit retina as labeled by [3H]SCH 23390, or as determined by adenylate cyclase activity. [3H]SCH 23390 binding in rabbit retinal membranes was stable, saturable and reversible. Scatchard analysis of [3H]SCH 23390 saturation data revealed a single high affinity binding site (K(d) = 0.175 ± 0.002 nM) with a maximum binding of 482 ± 12 fmol/mg of protein. The potencies of dopamine receptor agonists to stimulate [3H]acetylcholine release were correlated with their potencies to stimulate adenylate cyclase (r = 0.784, P < .05, n = 7) and with their affinities at [3H]SCH 23390 binding sites (r = 0.755, P > .05, n = 8). The potencies of antagonists to inhibit dopamine-evoked [3H]acetylcholine release were correlated with their potencies to inhibit the dopamine-stimulated adenylate cyclase (r = 0.759, P < .05, n = 5) and with their affinities at [3H]SCH 23390 binding sites (r = 0.998, P < .01, n = 7). We conclude that in rabbit retina dopamine evokes calcium-dependent [3H]acetylcholine release through activation of a site with the pharmacological characteristics of a D-1 dopamine receptor.

Original languageEnglish (US)
Pages (from-to)857-867
Number of pages11
JournalJournal of Pharmacology and Experimental Therapeutics
Volume243
Issue number3
StatePublished - 1987
Externally publishedYes

Fingerprint

Dopamine Receptors
Acetylcholine
Retina
Dopamine
Pharmacology
Rabbits
Dopamine Antagonists
Dopamine Agonists
Fenoldopam
Adenylyl Cyclases
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Butaclamol
Binding Sites
Pergolide
Flupenthixol
Perphenazine
Fluphenazine
Calcium
Sulpiride
Apomorphine

ASJC Scopus subject areas

  • Pharmacology

Cite this

Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina. / Hensler, J. G.; Cotterell, D. J.; Dubocovich, M. L.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 243, No. 3, 1987, p. 857-867.

Research output: Contribution to journalArticle

@article{8ab24c036d714f9d858e200ea0b39f3c,
title = "Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina",
abstract = "Superfusion with dopamine (0.1 μM-10 mM) evokes calcium-dependent [3H]acetylcholine release from rabbit retina labeled in vitro with [3H]choline. This effect is antagonized by the D-1 dopamine receptor antagonist SCH 23390. Activation or blockade of D-2 dopamine, alpha-2 or beta receptors did not stimulate or attenuate the release of [3H]acetylcholine from rabbit retina. Dopamine receptor agonists evoke the release of [3H]acetylcholine with the following order of potency: apomorphine ≥ SKF(R)82526 > SKF 85174 > SKF(R)38393 ≥ pergolide ≥ dopamine (EC50 = 4.5 μM) > SKF(S)82526 ≥ SKF(S)38393. Dopamine receptor antagonists inhibited the dopamine-evoked release of [3H]acetylcholine: SCH 23390 (IC50 = 1 nM) > (+)-butaclamol ≥ cis-fluphenthixol >fluphenazine > perphenazine > trans-flupenthixol > R-sulpiride. The potencies of dopamine receptors agonists and antagonists at the dopamine receptor mediating [3H]acetylcholine release is characteristic of the D-1 dopamine receptor. These potencies were correlated with the potencies of dopamine receptor agonists and antagonists at the D-1 dopamine receptor in rabbit retina as labeled by [3H]SCH 23390, or as determined by adenylate cyclase activity. [3H]SCH 23390 binding in rabbit retinal membranes was stable, saturable and reversible. Scatchard analysis of [3H]SCH 23390 saturation data revealed a single high affinity binding site (K(d) = 0.175 ± 0.002 nM) with a maximum binding of 482 ± 12 fmol/mg of protein. The potencies of dopamine receptor agonists to stimulate [3H]acetylcholine release were correlated with their potencies to stimulate adenylate cyclase (r = 0.784, P < .05, n = 7) and with their affinities at [3H]SCH 23390 binding sites (r = 0.755, P > .05, n = 8). The potencies of antagonists to inhibit dopamine-evoked [3H]acetylcholine release were correlated with their potencies to inhibit the dopamine-stimulated adenylate cyclase (r = 0.759, P < .05, n = 5) and with their affinities at [3H]SCH 23390 binding sites (r = 0.998, P < .01, n = 7). We conclude that in rabbit retina dopamine evokes calcium-dependent [3H]acetylcholine release through activation of a site with the pharmacological characteristics of a D-1 dopamine receptor.",
author = "Hensler, {J. G.} and Cotterell, {D. J.} and Dubocovich, {M. L.}",
year = "1987",
language = "English (US)",
volume = "243",
pages = "857--867",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina

AU - Hensler, J. G.

AU - Cotterell, D. J.

AU - Dubocovich, M. L.

PY - 1987

Y1 - 1987

N2 - Superfusion with dopamine (0.1 μM-10 mM) evokes calcium-dependent [3H]acetylcholine release from rabbit retina labeled in vitro with [3H]choline. This effect is antagonized by the D-1 dopamine receptor antagonist SCH 23390. Activation or blockade of D-2 dopamine, alpha-2 or beta receptors did not stimulate or attenuate the release of [3H]acetylcholine from rabbit retina. Dopamine receptor agonists evoke the release of [3H]acetylcholine with the following order of potency: apomorphine ≥ SKF(R)82526 > SKF 85174 > SKF(R)38393 ≥ pergolide ≥ dopamine (EC50 = 4.5 μM) > SKF(S)82526 ≥ SKF(S)38393. Dopamine receptor antagonists inhibited the dopamine-evoked release of [3H]acetylcholine: SCH 23390 (IC50 = 1 nM) > (+)-butaclamol ≥ cis-fluphenthixol >fluphenazine > perphenazine > trans-flupenthixol > R-sulpiride. The potencies of dopamine receptors agonists and antagonists at the dopamine receptor mediating [3H]acetylcholine release is characteristic of the D-1 dopamine receptor. These potencies were correlated with the potencies of dopamine receptor agonists and antagonists at the D-1 dopamine receptor in rabbit retina as labeled by [3H]SCH 23390, or as determined by adenylate cyclase activity. [3H]SCH 23390 binding in rabbit retinal membranes was stable, saturable and reversible. Scatchard analysis of [3H]SCH 23390 saturation data revealed a single high affinity binding site (K(d) = 0.175 ± 0.002 nM) with a maximum binding of 482 ± 12 fmol/mg of protein. The potencies of dopamine receptor agonists to stimulate [3H]acetylcholine release were correlated with their potencies to stimulate adenylate cyclase (r = 0.784, P < .05, n = 7) and with their affinities at [3H]SCH 23390 binding sites (r = 0.755, P > .05, n = 8). The potencies of antagonists to inhibit dopamine-evoked [3H]acetylcholine release were correlated with their potencies to inhibit the dopamine-stimulated adenylate cyclase (r = 0.759, P < .05, n = 5) and with their affinities at [3H]SCH 23390 binding sites (r = 0.998, P < .01, n = 7). We conclude that in rabbit retina dopamine evokes calcium-dependent [3H]acetylcholine release through activation of a site with the pharmacological characteristics of a D-1 dopamine receptor.

AB - Superfusion with dopamine (0.1 μM-10 mM) evokes calcium-dependent [3H]acetylcholine release from rabbit retina labeled in vitro with [3H]choline. This effect is antagonized by the D-1 dopamine receptor antagonist SCH 23390. Activation or blockade of D-2 dopamine, alpha-2 or beta receptors did not stimulate or attenuate the release of [3H]acetylcholine from rabbit retina. Dopamine receptor agonists evoke the release of [3H]acetylcholine with the following order of potency: apomorphine ≥ SKF(R)82526 > SKF 85174 > SKF(R)38393 ≥ pergolide ≥ dopamine (EC50 = 4.5 μM) > SKF(S)82526 ≥ SKF(S)38393. Dopamine receptor antagonists inhibited the dopamine-evoked release of [3H]acetylcholine: SCH 23390 (IC50 = 1 nM) > (+)-butaclamol ≥ cis-fluphenthixol >fluphenazine > perphenazine > trans-flupenthixol > R-sulpiride. The potencies of dopamine receptors agonists and antagonists at the dopamine receptor mediating [3H]acetylcholine release is characteristic of the D-1 dopamine receptor. These potencies were correlated with the potencies of dopamine receptor agonists and antagonists at the D-1 dopamine receptor in rabbit retina as labeled by [3H]SCH 23390, or as determined by adenylate cyclase activity. [3H]SCH 23390 binding in rabbit retinal membranes was stable, saturable and reversible. Scatchard analysis of [3H]SCH 23390 saturation data revealed a single high affinity binding site (K(d) = 0.175 ± 0.002 nM) with a maximum binding of 482 ± 12 fmol/mg of protein. The potencies of dopamine receptor agonists to stimulate [3H]acetylcholine release were correlated with their potencies to stimulate adenylate cyclase (r = 0.784, P < .05, n = 7) and with their affinities at [3H]SCH 23390 binding sites (r = 0.755, P > .05, n = 8). The potencies of antagonists to inhibit dopamine-evoked [3H]acetylcholine release were correlated with their potencies to inhibit the dopamine-stimulated adenylate cyclase (r = 0.759, P < .05, n = 5) and with their affinities at [3H]SCH 23390 binding sites (r = 0.998, P < .01, n = 7). We conclude that in rabbit retina dopamine evokes calcium-dependent [3H]acetylcholine release through activation of a site with the pharmacological characteristics of a D-1 dopamine receptor.

UR - http://www.scopus.com/inward/record.url?scp=0023599990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023599990&partnerID=8YFLogxK

M3 - Article

C2 - 2961878

AN - SCOPUS:0023599990

VL - 243

SP - 857

EP - 867

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -